ReP USP - Resultado da busca

Filtros : "Farsky, Sandra Helena Poliselli" "European Journal of Pharmaceutics and Biopharmaceutics" Removido: "Indexado no: PubMed" Limpar

Filtros

USP affiliated authors
- araki, koiti (2)
- farsky, sandra helena poliselli (2)
- leão, matheus de castro (2)
- uchiyama, mayara klimuk (2)
- broering, milena fronza (1)

Date published
- 2022 (~1)
- 2021 (~1)
Subjects
- arteriosclerose (1)
- células epiteliais (1)
- enteropatias inflamatórias (1)
- estresse oxidativo (1)
- macrófagos (1)

Artigo de periodico
Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis (2022)
Broering, Milena Fronza ; Leão, Matheus de Castro; Rocha, Gustavo Henrique Oliveira da ; Scharf, Pablo Rhasan dos Santos ; Xavier, Luana Filippi; Alves, Aline de Cristo Soares ; Castro, Inar Alves de ; Reutelingsperger, Chris ; Uchiyama, Mayara Klimuk ; Araki, Koiti ; Guterres, Sílvia Stanisçuaski ; Pohlmann, Adriana Raffin ; Farsky, Sandra Helena Poliselli
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: IQ, FCF
Subjects: CÉLULAS EPITELIAIS, ENTEROPATIAS INFLAMATÓRIAS, MACRÓFAGOS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BROERING, Milena Fronza et al. Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis. European Journal of Pharmaceutics and Biopharmaceutics, v. 181, p. 49-59, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2022.10.022. Acesso em: 10 nov. 2024.
APA
Broering, M. F., Leão, M. de C., Rocha, G. H. O. da, Scharf, P. R. dos S., Xavier, L. F., Alves, A. de C. S., et al. (2022). Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis. European Journal of Pharmaceutics and Biopharmaceutics, 181, 49-59. doi:10.1016/j.ejpb.2022.10.022
NLM
Broering MF, Leão M de C, Rocha GHO da, Scharf PR dos S, Xavier LF, Alves A de CS, Castro IA de, Reutelingsperger C, Uchiyama MK, Araki K, Guterres SS, Pohlmann AR, Farsky SHP. Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2022 ; 181 49-59.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ejpb.2022.10.022
Vancouver
Broering MF, Leão M de C, Rocha GHO da, Scharf PR dos S, Xavier LF, Alves A de CS, Castro IA de, Reutelingsperger C, Uchiyama MK, Araki K, Guterres SS, Pohlmann AR, Farsky SHP. Development of Annexin A1-surface-functionalized metal-complex multi-wall lipid core nanocapsules and effectiveness on experimental colitis [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2022 ; 181 49-59.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ejpb.2022.10.022
Artigo de periodico
Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression (2021)
Leão, Matheus de Castro; Pohlmann, Adriana Raffin ; Alves, Aline de Cristo Soares; Farsky, Sandra Helena Poliselli ; Uchiyama, Mayara Klimuk ; Araki, Koiti ; Sandri, Silvana; Guterres, Sílvia Stanisçuaski ; Castro, Inar Alves de
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FCF, IQ
Subjects: ARTERIOSCLEROSE, ESTRESSE OXIDATIVO, ÁCIDOS GRAXOS OMEGA 3, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEÃO, Matheus de Castro et al. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. European Journal of Pharmaceutics and Biopharmaceutics, v. 159, p. 99–107, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2020.12.016. Acesso em: 10 nov. 2024.
APA
Leão, M. de C., Pohlmann, A. R., Alves, A. de C. S., Farsky, S. H. P., Uchiyama, M. K., Araki, K., et al. (2021). Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. European Journal of Pharmaceutics and Biopharmaceutics, 159, 99–107. doi:10.1016/j.ejpb.2020.12.016
NLM
Leão M de C, Pohlmann AR, Alves A de CS, Farsky SHP, Uchiyama MK, Araki K, Sandri S, Guterres SS, Castro IA de. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 159 99–107.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ejpb.2020.12.016
Vancouver
Leão M de C, Pohlmann AR, Alves A de CS, Farsky SHP, Uchiyama MK, Araki K, Sandri S, Guterres SS, Castro IA de. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 159 99–107.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.ejpb.2020.12.016

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024